Page last updated: 2024-09-04

imidazole-4-carboxamide and Breast Neoplasms

imidazole-4-carboxamide has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, HI; Kim, HS; Kim, JH; Kim, N; Kim, SJ; Lee, HJ; Lee, JO; Lee, YW; Park, SH1

Other Studies

1 other study(ies) available for imidazole-4-carboxamide and Breast Neoplasms

ArticleYear
Paclitaxel suppresses the viability of breast tumor MCF7 cells through the regulation of EF1α and FOXO3a by AMPK signaling.
    International journal of oncology, 2015, Volume: 47, Issue:5

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Breast Neoplasms; Cell Survival; Female; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Paclitaxel; Peptide Elongation Factor 1; Signal Transduction

2015